Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in…
Accutar Biotechnology,, a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announced that the U.S. Food and…